Melissa McCarthy and Barbra Streisand's exchange about Ozempic creates a frenzy online. Find out what happened in this hilarious drama!
Barbra Streisand recently commented on Melissa McCarthy's Instagram post, inquiring if she used Ozempic, sparking a humorous back-and-forth between the two celebrities. Streisand later clarified that she intended her question as a compliment towards McCarthy's appearance, leading to a wave of social media reactions. The exchange between the singer and actress escalated, with even Richard Simmons weighing in on the playful drama. Despite the lighthearted banter, the incident brought attention to the sensitive nature of commenting on someone's weight loss journey in the public eye.
Barbra Streisand commented on Melissa McCarthy's Instagram post asking if she used Ozempic, and later said she was trying to pay her a "compliment."
Melissa McCarthy had a hilarious reaction after Barbra Streisand asked if she took Ozempic in an Instagram comment.
The singer just wanted to tell Melissa McCarthy how great she was looking. Was it a good idea to mention a weight-loss drug?
The drama between Melissa McCarthy and Barbra Streisand over an Ozempic question ain't over yet ... 'cause Richard Simmons is now weighing on the matter.
"The takeaway, Barbra Streisand knows I exist," McCarthy said in a fun Instagram video of herself reading a magazine celebrating the singer and actress.
McCarthy, known for films such as Bridesmaids and The Heat, had posted an image of herself on Instagram before Streisand replied by asking if she had taken ...
While people are questioning Barbra's definition of the word “compliment,” Melissa herself has leaped to Barbra's defense and totally downplayed the awkward ...
The popularity of their weight loss treatments has boosted the fortunes of names such as Novo Nordisk (NYSE:NVO) and Eli Lilly (NYSE:LLY) in recent times.
Experts say that those curious about someone's weight loss – no matter how well-meaning they may be – should tread carefully.
Melissa McCarthy laughed off Barbra Streisand's comment about Ozempic, saying she loves the pop icon and there are no hard feelings.
Ozempic can be given to people with HIV to combat fatty liver, according to a recent peer-reviewed study.
The drug used to treat diabetes surged in popularity last year as many turned to it to lose weight. A comment Barbra ...
The U.S. Federal Trade Commission (FTC) is not done with its crackdown on what it views as improper listing of patents with the FDA.
In a bid to improve competition in the industry, the U.S. Federal Trade Commission is challenging the patents of 20 different pharmaceutical products, ...
Today's biotech news includes Akili's layoffs and unpopular ADHD video game treatment, Bristol Meyers Squibb's appeal, and more.
Barbra Streisand is seemingly taken aback by the backlash over an Ozempic comment she left on Melissa McCarthy's latest Instagram post.
The move broadens the antitrust regulator's ongoing campaign against allegedly “improper or inaccurate” patent listings by drugmakers. Published May 1, 2024.
Melissa McCarthy has responded to Barbra Streisand's Ozempic comment, writing in part, "She thought I look good! I win the day."
Streisand explained that she “forgot the world is reading!” when she commented on McCarthy's Instagram post asking if she'd taken weight loss drugs.
Isis Navarro Reyes Allegedly Sold Misbranded Adulterated Weight Loss Drugs to Customers Without a License to Administer Such Drugs.
A Long Island woman was busted for illegally peddling tainted weight loss drugs, including Ozempic, on TikTok, the feds allege.
Barbra Streisand asked Melissa McCarthy in a since-deleted comment on Instagram if she was taking Ozempic. The rogue question went viral on social media, ...
Federal regulators are challenging patents on 20 brand-name drugs, including the blockbuster weight-loss injection semaglutide (Ozempic, Wegovy), ...
Denmark will start putting patients suffering from type 2 diabetes on cheaper drugs before prescribing so-called GLP-1 drugs such as Novo Nordisk's Ozempic, ...
The drugmaker's meteoric rise has also been a boon for the economy, which would have stagnated last year without Novo's massive investments, expanding ...
It's a popular drug that millions of people are taking to lose weight, but the federal government and doctors are warning users about some versions of the ...